How much is the vascular tissue matrix market worth, and how is it expected to expand?
The vascular tissue matrix market size has grown strongly in recent years. It will grow from $1.2 $ billion in 2024 to $1.3 $ billion in 2025 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to the advancements in tissue engineering, the aging population, the rising number of surgical procedures, and the development of biocompatible materials.
The vascular tissue matrix market size is expected to see strong growth in the next few years. It will grow to $1.76 $ billion in 2029 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to the increasing incidence of cardiovascular diseases (CVDs), advancements in regenerative medicine, rising awareness of organ and tissue donation, and government initiatives and funding. Major trends in the forecast period include collaborations and partnerships, the emergence of biodegradable and bioengineered matrices, rising awareness and early diagnosis, favorable government initiatives, and expansion of healthcare infrastructure.
Get Your Free Sample of The Global Vascular Tissue Matrix Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19746&type=smp
Which industry factors have accelerated the vascular tissue matrix market’s expansion?
The rising adoption of minimally invasive procedures is expected to propel the growth of the vascular tissue matrix market going forward. Minimally invasive procedures are medical or surgical interventions that require only small incisions or no incisions at all. The demand for minimally invasive procedures is on the rise due to their reduced recovery times, lower risk of complications, and lower post-operative pain compared to traditional surgeries. A vascular tissue matrix is used in minimally invasive procedures to support and regenerate blood vessels without the need for extensive surgery. For instance, in January 2024, Intuitive Surgical Inc., a US-based manufacturer of robotic products, reported that they had placed 415 da Vinci surgical systems (robotic surgical systems that use a minimally invasive surgical approach) in the fourth quarter of 2023, representing a 12% increase compared to 2022. Therefore, the growth of minimally invasive procedures is driving the growth of the vascular tissue matrix market.
What are the primary segments of the vascular tissue matrix market?
The vascular tissue matrixmarket covered in this report is segmented –
1) By Type: Biologic Matrix, Synthetic Matrix
2) By Therapeutic Area: Orthopedics, Dermatology, Cardiology, Neurology, Oncology, Others Therapeutic
3) By Application: Hospital, Clinic, Other Applications
Subsegments:
1) By Biologic Matrix: Allograft Matrix, Xenograft Matrix, Autograft Matrix, Decellularized Matrix
2) By Synthetic Matrix: Polymer-Based Matrix, Hydrogel Matrix, Nanofiber Matrix
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/vascular-tissue-matrix-global-market-report
Which firms are leading the vascular tissue matrix market?
Major companies operating in the vascular tissue matrix market are Abbott Laboratories, Medtronic PLC, Stryker Corporation, Baxter International Inc., Boston Scientific Corporation, Terumo Corporation, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., Coloplast Group, Getinge Group, Integra LifeSciences Corporation, LivaNova PLC, C. R. Bard Inc., Artivion Inc., CryoLife Inc., LeMaitre Vascular Inc., Kensey Nash Corporation, Cardiva Medical Inc., Lombard Medical Technologies, Genzyme Corporation, Cook Medical Inc., Humacyte Inc., BioCardia Inc.
Which market trends are set to define the future of the vascular tissue matrix market?
Major companies operating in the vascular tissue matrix market are increasing their focus on developing innovative products, such as tissue matrix derived from human umbilical cord extracellular matrix (ECM), to gain a competitive edge in the market. A tissue matrix derived from the human umbilical cord extracellular matrix is a scaffold composed of the structural proteins and molecules found in the extracellular matrix of the umbilical cord. For instance, in February 2024, StimLabs LLC, a US-based biotechnology company, announced that the U.S. Food and Drug Administration (FDA) granted 510(k) clearance for its novel wound care device, Corplex P. This device, the first graft derived from the human umbilical cord ECM, is designed for treating acute and chronic wounds. It contains connective tissue matrix components, including collagens and glycosaminoglycans like hyaluronic acid, providing a porous scaffold to support cellular infiltration and tissue regeneration. Corplex P is intended to manage various types of wounds, including partial and full-thickness wounds, pressure ulcers, diabetic ulcers, surgical wounds, and trauma wounds.
Which geographic trends are shaping the vascular tissue matrix market, and which region has the highest market share?
North America was the largest region in the vascular tissue matrix market in 2024. The regions covered in the vascular tissue matrix market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Vascular Tissue Matrix Market Report 2025 Offer?
The vascular tissue matrix market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
A vascular tissue matrix refers to a biomaterial scaffold designed to support the growth, repair, or regeneration of vascular tissues, which are tissues associated with blood vessels, including arteries, veins, and capillaries. This matrix provides a three-dimensional framework that mimics the extracellular matrix (ECM) of natural vascular tissues, facilitating the attachment, proliferation, and differentiation of cells.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19746
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
